enterade® 's Patient Care Blog

Clinical Trial to Assess How enterade® Helps Retain Fluids and Reduce Diarrhea in Carcinoid Syndrome and Neuroendocrine Tumor Patients NORWOOD, Mass., December 12, 2018 – Entrinsic Health Solut...

Cancer patients undergoing treatment can experience debilitating side effects, such as dehydration and damage to the gastrointestinal (GI) system – significantly impacting their quality of life and...

University of Florida startup Entrinsic Health Solutions Inc. (EHS), an innovative health sciences company, has entered into a partnership that provides for a worldwide commercial license and suppl...

— Partnership provides worldwide commercial license and supply agreement for enterade®, an amino acid-based, glucose-free, electrolyte solution designed for oncology and gastrointestinal disease pa...

We are widening the NET! This year, we want to highlight organizations raising awareness about neuroendocrine tumor (NET) cancer – a rare and commonly misdiagnosed form of cancer. NET cancer is fre...

Get the Word Out Use the hashtags #cureNETs #worldNETcancerday #netcancer #neuroendocrine #incalliance #letstalkaboutnets #NETs Share these Key Messages about NET Cancer 5...

Across the globe, people are mourning the loss of Aretha Franklin, who brought people joy through her music and touched minds and hearts through her voice. Her iconic career in the music industry w...

Q&A with Rachel C. Miller Registered Dietitian Consultant at University of Kentucky Markey Cancer Center After a neuroendocrine tumor (NET) diagnosis, many patients wonder what changes need t...

Earlier this month, thousands of healthcare professionals, scientists, and patients gathered together in Chicago to hear the latest scientific breakthroughs redefining cancer care at the American...

 Aman Chauhan, MBBS, University of Kentucky explains enterade® Amino Acid Based Rehydration Solution | 70% of Patients Had Benefit in Diarrhea Reduction at Annual Meeting 2018 Click on the link ...

Living with carcinoid cancer isn’t easy. Like many carcinoid patients, I had been experiencing symptoms for years, but originally thought it was irritable bowel syndrome (IBS). Since these tumors g...

Until recently, car trips posed an embarrassing challenge to K. Adams of Oklahoma City. Adams, 38, is a 19-year survivor of gastroenteropancreatic neuroendocrine tumors, or GEP-NETs. Over the year...